Heidelberg Pharma AG
XMUN:HPHA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Heidelberg Pharma AG
XMUN:HPHA
|
DE |
|
T
|
Thales SA
XMUN:CSF
|
FR |
|
M
|
Mitsubishi Estate Co Ltd
XMUN:MES
|
JP |
|
H
|
Halliburton Co
F:HAL
|
US |
|
A
|
Anglo American Platinum Ltd
XMUN:RPHA
|
ZA |
|
Fuji Oil Co Ltd
F:ACK
|
JP |
|
Chemometec A/S
F:CHY
|
DK |
|
Loandepot Inc
F:LDD
|
US |
|
Gurit Holding AG
F:GVM0
|
CH |
|
P
|
Paychex Inc
XMUN:PCX
|
US |
|
A
|
Allianz SE
F:ALV
|
DE |
|
M
|
Microsoft Corp
XMUN:MSF
|
US |
|
C
|
Capital One Financial Corp
F:CFX
|
US |
|
A
|
Alaska Air Group Inc
XMUN:ALK
|
US |
|
D
|
Dominion Energy Inc
XMUN:DOD
|
US |
|
F
|
Farmland Partners Inc
F:0FA
|
US |
|
U
|
US Physical Therapy Inc
F:UPH
|
US |
Wall St Price Targets
HPHA Price Targets Summary
Heidelberg Pharma AG
According to Wall Street analysts, the average 1-year price target for HPHA is 5.57 EUR with a low forecast of 5.51 EUR and a high forecast of 5.73 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HPHA's stock price target?
Price Target
5.57
EUR
According to Wall Street analysts, the average 1-year price target for HPHA is 5.57 EUR with a low forecast of 5.51 EUR and a high forecast of 5.73 EUR.
What is the Revenue forecast for Heidelberg Pharma AG?
Projected CAGR
202%
Over the last 9 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 2 years is 202%.
What is the Gross Profit forecast for Heidelberg Pharma AG?
Projected CAGR
26%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 5 years is 26%.
